MTRE Advanced Technologies Ltd.

MTRE Advanced Technologies Ltd. is a medical technology company based in Israel that has been dedicated to developing, manufacturing, and marketing innovative non-invasive solutions for body temperature control since 1998. The company's products are designed to enable healthcare providers to exercise precise and timely control of body temperature, offering significant medical and economical benefits across various medical applications and disciplines, including cardio-vascular, organ transplant, pediatric, neurosurgery, and trauma. Additionally, MTRE is at the forefront of developing Neuroprotective Cooling Therapy for stroke, cardiac arrest, and Traumatic Brain Injury (TBI) victims. MTRE’s proprietary human body temperature management technology serves as the foundation for its novel, revolutionary non-invasive solutions. These solutions are expected to make a substantial impact in the medical field. With a focus on non-invasive approaches, the company is poised to address critical needs in temperature control, particularly in life-saving and life-improving procedures. Given the market potential and the growing demand for effective temperature management solutions, MTRE's dedication to non-invasive technology positions it well in the manufacturing industry. While the specific details of the last investment and investors are not available, the potential for growth and impact in critical medical fields make MTRE Advanced Technologies Ltd. an intriguing venture for potential investors seeking to back cutting-edge advancements in medical technology.